These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19400764)

  • 1. Antifungal drug resistance mechanisms.
    Pemán J; Cantón E; Espinel-Ingroff A
    Expert Rev Anti Infect Ther; 2009 May; 7(4):453-60. PubMed ID: 19400764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic
    Czajka KM; Venkataraman K; Brabant-Kirwan D; Santi SA; Verschoor C; Appanna VD; Singh R; Saunders DP; Tharmalingam S
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.
    Beardsley J; Halliday CL; Chen SC; Sorrell TC
    Future Microbiol; 2018 Aug; 13(10):1175-1191. PubMed ID: 30113223
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Černáková L; Roudbary M; Brás S; Tafaj S; Rodrigues CF
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922907
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifungal resistance: why are we losing this battle?
    Paiva Macedo J; Dias VC
    Future Microbiol; 2024; 19(11):1027-1040. PubMed ID: 38904325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal pharmacokinetics and pharmacodynamics.
    Lepak AJ; Andes DR
    Cold Spring Harb Perspect Med; 2014 Nov; 5(5):a019653. PubMed ID: 25384765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent drug development and treatments for fungal infections.
    Roy M; Karhana S; Shamsuzzaman M; Khan MA
    Braz J Microbiol; 2023 Sep; 54(3):1695-1716. PubMed ID: 37219748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on fungal lipid biosynthesis inhibitors as antifungal agents.
    Vishwakarma M; Haider T; Soni V
    Microbiol Res; 2024 Jan; 278():127517. PubMed ID: 37863019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in antifungal treatment: What is coming up?
    Guinea J
    Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):59-63. PubMed ID: 37997874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
    White TC; Marr KA; Bowden RA
    Clin Microbiol Rev; 1998 Apr; 11(2):382-402. PubMed ID: 9564569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising immunotherapeutic targets for treating candidiasis.
    Feng Z; Lu H; Jiang Y
    Front Cell Infect Microbiol; 2024; 14():1339501. PubMed ID: 38404288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling multi-drug resistant fungi by efflux pump inhibitors.
    Engle K; Kumar G
    Biochem Pharmacol; 2024 Aug; 226():116400. PubMed ID: 38945275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies.
    Mota Fernandes C; Del Poeta M
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1083-1092. PubMed ID: 32673125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal chemicals promising function in disease prevention, method of action and mechanism.
    Dominguez JAJ; Luque-Vilca OM; Mallma NES; FLores DDC; Zea CYH; Huayhua LLA; Lizárraga-Gamarra FB; Cáceres CGM; Yauricasa-Tornero SV; Paricanaza-Ticona DC; Cajavilca HLV
    Braz J Biol; 2024; 83():e275055. PubMed ID: 38422253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transcriptional control of antifungal resistance in human fungal pathogens.
    Sharma C; Kadosh D
    Crit Rev Microbiol; 2023 Aug; 49(4):469-484. PubMed ID: 35634915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses.
    Gómez-Gaviria M; Contreras-López LM; Aguilera-Domínguez JI; Mora-Montes HM
    Infect Drug Resist; 2024; 17():2641-2658. PubMed ID: 38947372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling machine learning and epidemiological modelling to characterise optimal fungicide doses when fungicide resistance is partial or quantitative.
    Taylor NP; Cunniffe NJ
    J R Soc Interface; 2023 Apr; 20(201):20220685. PubMed ID: 37073520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant fungal infection: a matter of importance not only in critical COVID patients.
    Seijas Betolaza I; Higuera Lucas J; Barrios Andres JL; López Soria LM; Boado Varela V
    Minerva Anestesiol; 2024 Mar; 90(3):213-214. PubMed ID: 37987994
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.
    Pfaller MA
    Am J Med; 2012 Jan; 125(1 Suppl):S3-13. PubMed ID: 22196207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    Garnaud C; Botterel F; Sertour N; Bougnoux ME; Dannaoui E; Larrat S; Hennequin C; Guinea J; Cornet M; Maubon D
    J Antimicrob Chemother; 2015 Sep; 70(9):2556-65. PubMed ID: 26017039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.